Shockwave Medical, Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Shockwave Medical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q1 2024.
  • Shockwave Medical, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was $42.4M, a 6.51% increase year-over-year.
  • Shockwave Medical, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was $162M, a 8.82% increase year-over-year.
  • Shockwave Medical, Inc. annual Operating Income (Loss) for 2023 was $159M, a 28.2% increase from 2022.
  • Shockwave Medical, Inc. annual Operating Income (Loss) for 2022 was $124M.
  • Shockwave Medical, Inc. annual Operating Income (Loss) for 2021 was -$871K, a 98.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $162M $42.4M +$2.59M +6.51% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $159M $43.3M +$859K +2.03% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $158M $43.6M +$6.86M +18.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $151M $32.4M +$2.8M +9.46% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $149M $39.8M +$24.4M +159% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $124M $42.4M +$28.4M +203% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $95.7M $36.8M +$34M +1207% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $61.7M $29.6M +$29.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $32M $15.4M +$32.9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$871K $14M +$29.8M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$30.7M $2.81M +$15.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$46.3M -$180K +$17.8M +99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$64.2M -$17.5M +$1.49M +7.86% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$65.7M -$15.9M -$504K -3.28% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$65.2M -$12.8M +$258K +1.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$65.4M -$18M -$6.76M -60.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$58.7M -$19M -$6.82M -56.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$51.8M -$15.4M -$4.23M -38% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$47.6M -$13.1M -$2.99M -29.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$44.6M -$11.3M -$1.06M -10.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$43.6M -$12.2M -$2.36M -24% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$41.2M -$11.1M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$10.1M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$10.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$9.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.